Todd C. Davis, Director at LIGAND PHARMACEUTICALS INC (LGND), bought 1,000 shares at $93.59 ($94K) on 2019-08-02, disclosed to the SEC on 2019-08-05.
Open-market purchase of $94k LGND by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| LGND | BUY | 2024-08-09 | $243K | — | Filing → |
| LGND | BUY | 2023-09-25 | $238K | — | Filing → |
| LGND | SELL | 2021-02-12 | $2.2M | — | Filing → |